Accessibility Menu
Micro-X logo

Micro-X(ASX) MX1

Market CapA$15.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-96%
5 Year-93%
1 Year-77%
1 Month-29%
A$0.02
-4.76%
-0.00Today
Micro-X last closing stock price
MetricPriceDate
Last closeAUD 0.022026-09-08
Micro-X stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-20%AUD 0.032026-09-01
1 month-28.57%AUD 0.032026-08-07
3 month-48.72%AUD 0.042026-06-10
Year to date-80.95%AUD 0.112025-12-31
1 year-77.01%AUD 0.092025-09-08
3 year-82.61%AUD 0.122023-09-08
5 year-92.86%AUD 0.282021-09-09
Since inception-96.37%AUD 0.582015-12-22

Micro-X Financials at a Glance

Market Cap

A$15.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$28.14M

Net Income (TTM)

-A$23.77M

EPS (TTM)

-A$0.01

P/E Ratio

-1.48

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Price

A$0.02

Volume

674,774

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.02 - A$0.12

Estimated Earnings Date

Feb 26, 2027

MX1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Micro-X

Micro-X Limited is an innovative company specializing in the design, development, and manufacturing of advanced imaging products for healthcare, defense, and security markets. Utilizing cutting-edge cold cathode X-ray technology, Micro-X aims to revolutionize imaging solutions across various sectors.

Products and Services
  • Carbon nanotube-based X-ray products for diverse applications
  • Mobile medical imaging systems like Rover Plus and Head CT
  • Advanced security solutions including CT baggage scanners and self-screening checkpoints
Growth Outlook
  • Recent quarterly revenue increased to AUD 10.1 million, showing strong market demand
  • Expansion into international markets enhances growth potential
  • Innovative product pipeline expected to drive future revenue growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 30.5 million
  • Current ratio of 1.45 indicates strong short-term financial health
  • Net income for the latest quarter was AUD -6.6 million, reflecting ongoing investment in R&D
Micro-X Limited operates in a dynamic industry, focusing on advanced imaging technologies that cater to critical sectors. The company's innovative approach and commitment to research and development position it well for future growth. Recent financial performance indicates a solid revenue trajectory, while the current ratio suggests a healthy balance sheet. As Micro-X continues to expand its product offerings and market reach, it remains a compelling option for investors interested in the medical devices sector.
AI Generated • Aug 17, 2026

Industry

Healthcare Equipment and Supplies

CEO

Kingsley Campbell Hall

Headquarters

Adelaide, SA 5042, AU

MX1 Financials

Key Financial Metrics (TTM)

Gross Margin

-60.66%

Operating Margin

-104.71%

Net Income Margin

-65.46%

Return on Equity

-188.06%

Return on Capital

-138.70%

Return on Assets

-50.09%

Earnings Yield

-67.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$15.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

752.33M

Volume

674.77K

Avg. Volume

659.46K

Financials (TTM)

Gross Profit

-A$3.17M

Operating Income

-A$29.09M

EBITDA

-A$30.83M

Operating Cash Flow

-A$17.51M

Capital Expenditure

-A$244.00K

Free Cash Flow

-A$17.76M

Cash & ST Invst.

A$3.14M

Total Debt

A$6.48M

Micro-X Performance Analysis

Micro-X annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 15,005,00067.3%
20242024-06-30AUD 15,222,0001.4%
20252025-06-30AUD 13,053,000-14.2%
20262026-06-30AUD 15,087,00015.6%
Micro-X sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-315.3%
Q42025-06-30-23.6%
Q22025-12-3178.8%
Q42026-06-30-50.7%
Micro-X annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.02-41.6%
20242024-06-30AUD -0.02-14.4%
20252025-06-30AUD -0.0223.9%
20262026-06-30AUD -0.01-38.2%
Micro-X sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-282.1%
Q42025-06-3045.0%
Q22025-12-31-20.7%
Q42026-06-3055.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$4.98M

-29.1%

Gross Profit

-A$6.66M

-314.3%

Gross Margin

-1.34%

N/A

Market Cap

A$15.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.99K

N/A

Employees

7,935

N/A

Net Income

-A$3.26M

-55.0%

EBITDA

-A$9.63M

-26.7%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$3.14M

-2.9%

Total Debt

A$6.48M

+62.4%

Accounts Receivable

A$7.39M

-27.3%

Inventory

A$4.02M

-25.3%

Long Term Debt

A$2.74M

-16.8%

Short Term Debt

A$3.74M

+439.7%

Return on Assets

-50.09%

N/A

Return on Invested Capital

-1.88%

N/A

Free Cash Flow

-A$6.01M

+17.0%

Operating Cash Flow

-A$5.88M

+17.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSS.AXGenetic Signatures Limited
A$0.09+7.41%
IPD.AXImpediMed Limited
A$0.01+0.00%
PCK.AXPainChek Limited
A$0.12+4.55%
BMT.AXBeamtree Holdings Limited
A$0.11-4.35%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.03+0.03%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.34-0.10%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$117.28+0.10%
INTCIntel
$95.80+0.05%

Questions About MX1

What is the current price of Micro-X?

Micro-X is trading at A$0.02 per share.

What is the 52-week range for Micro-X?

Over the past 52 weeks, Micro-X has traded between A$0.02 and A$0.12.

How much debt does Micro-X have?

As of the most recent reporting period, Micro-X reported total debt of A$6.52M.

How much cash does Micro-X have on hand?

Micro-X reported A$3.14M in cash and cash equivalents in its most recent financial results.

What is Micro-X’s dividend yield?

Micro-X does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.